---
title: Advancing Early-Phase Clinical Trials with Automated Euglycemic Glucose Clamps
description: Explore how Automated Euglycemic Glucose Clamps with Profil’s ClampArt® technology deliver gold-standard accuracy in insulin action studies.
---

[Profil Blog ](https://blog.profil.com/blog)

# [Advancing Early-Phase Clinical Trials with Automated Euglycemic Glucose Clamps](https://blog.profil.com/blog/euglycemic-glucose-clamps)

 Written by [Christopher Haiduk](https://blog.profil.com/blog/author/christopher-haiduk) | Apr 23, 2025 1:38:00 PM

#### Advancing Diabetes & Metabolic Research with Fully Automated Glucose Clamps

At [Profil](https://www.profil.com), we set the gold standard in clamp methodology with **ClampArt®**, our proprietary fully automated [glucose clamp](https://www.profil.com/services/hyperinsulinemic-euglycemic-clamp) device. As the only CRO worldwide using fully automated clamps, we deliver unmatched precision in evaluating insulin action and glucose-lowering therapies.

##### What Makes Automated Euglycemic Glucose Clamps Essential?

This state-of-the-art technique ensures continuous, real-time blood glucose monitoring and automatically adjusts the glucose infusion rate (GIR) every minute. Unlike manual methods, ClampArt® eliminates investigator bias, ensuring superior data accuracy and consistency.

##### How it Works:

- **Fully Automated Precision:** Continuous glucose monitoring with minute-by-minute GIR adjustments.
- **Standardized & Reproducible:** Reduces variability and ensures high data quality.
- **Efficient & Scalable:** Profil’s advanced infrastructure enables the simultaneous execution of multiple glucose clamps, optimizing trial efficiency and data collection.

##### Key Benefits for Clinical Trials:

- **Unmatched Accuracy:** Eliminates human error, optimizing pharmacodynamic (PD) assessments.
- **Enhanced Patient Safety & Comfort:** Controlled glucose regulation ensures a smooth experience for participants.
- **Comprehensive Insights:** Evaluates insulin onset of action, peak action, duration of action, and variability with high precision.

##### Why Choose Profil?

With more glucose clamps performed than any other institution worldwide, Profil leads the way in **early-phase trials for novel insulins, biosimilars, and glucose-lowering therapies**. Our proprietary ClampArt® technology ensures gold-standard metabolic research that drives drug development forward.

 

##### Stay ahead of the innovation

Follow us for more insights on how Profil and ClampArt® are redefining clinical trial methodologies in metabolic research. Also you can watch our online seminar session about glucose clamps with ClampArt® [here](https://info.profil.com/online-seminar-on-demand-glucose-clamps).

 

[View full post](https://blog.profil.com/blog/euglycemic-glucose-clamps)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Christopher Haiduk"
  },
  "dateModified" : "2025-04-23T13:38:00.391Z",
  "datePublished" : "2025-04-23T13:38:00Z",
  "headline" : "Advancing Early-Phase Clinical Trials with Automated Euglycemic Glucose Clamps",
  "image" : {
    "@type" : "ImageObject",
    "height" : 272,
    "url" : "https://481167.fs1.hubspotusercontent-na1.net/hubfs/481167/Header_1077x400px_Clamp_Art_520x272.jpg",
    "width" : 520
  },
  "mainEntityOfPage" : "https://blog.profil.com/blog/euglycemic-glucose-clamps",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "Blog"
  }
}
```